Reason: Lack of Assurance of Sterility
Distributed: Product was distributed to two (2) direct accounts in RI and CO.Reason: Lack of Assurance of Sterility
Distributed: Product was distributed to two (2) direct accounts in RI and CO.Reason: Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.
Distributed: Distributed Nationwide in the USAReason: Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
Distributed: Distributed nationwide to 68 consignees in the U.S.Reason: Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Distributed: Nationwide in the USAReason: Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.
Distributed: Nationwide in the US.Reason: Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.
Distributed: Nationwide in the US.Reason: Product mix-up: Cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste
Distributed: Affected product was distributed to nineteen (19) consignees within the united states.Reason: Cases of Sodium Fluoride 1.1% Prescription Dental Toothpaste may contain cartons labeled as Capsaicin Cream 0.025% but contain correctly labeled tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste
Distributed: Affected product was distributed to nineteen (19) consignees within the united states.Reason: Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.
Distributed: The recall product was distributed nationwide.